FREDUN

Fredun Pharmaceuticals Ltd.

BSE: 539730

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

1,223.50-18.5 (-1.49%)

10 Aug, 12:00 AM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

86.9 / 100

Value Score

43.4 / 100

Price Momentum Score

97.9 / 100

QVM Score

95.4 / 100

Key Metrics

Market Cap

2023.42

P/E (TTM)

47.22

P/B

7.28

P/S (TTM)

2.72

EV/EBITDA

20.08

CAPE (5Y)

34.91

ROE (TTM)

15.83

ROCE (TTM)

20.05

ROA (TTM)

5.88

Avg 3Y ROE

15.06

Earnings 3Y CAGR

39.56

Sales 3Y CAGR

37.40

Sales 5Y CAGR

35.08

Debt/Equity

0.87

Consensus TP

Strong Buy %

Promoter Holding

44.57

Pledged %

0.00

Stock Analysis

Fundamental analysis overview of Fredun Pharmaceuticals Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Strong price momentum

Price Momentum score of 97.9 indicates that the stock has strong price momentum. Research has shown that stocks with higher momentum continue to outperform in the near term

What is Price Momentum score?

97.9 / 100

High and stable ROE

The company reported strong ROE of 15.83% for 12-month ended 30 Jun 2026 and ROE improved marginally by 81 bps from 1 year ago

What is ROE (FY)?

Moderate operating margin but improving trend

The company reported moderate operating margin of 13.02% for 12-month ended 30 Jun 2026 but operating margin improved by 220 bps from 1 year ago

What is Operating profit margin?

Strong revenue growth and above median growth of industry

The company delivered strong revenue growth of 50.32% for 12-month ended 30 Jun 2026 and the growth was 38.89 percentage points higher than median growth of industry

What is Sales growth (1Y)?

Median: 11.43

Value 50.32

-42.89734.5

Strong EPS growth and above median growth of industry

The company delivered strong EPS growth of 46.58% for 12-month ended 30 Jun 2026 and the growth was 36.15 percentage points higher than median growth of industry

What is EPS growth (1Y)?

Low and declining Debt to Equity

The company has low Debt to Equity of 0.87 as on 30 Jun 2026 and Debt to Equity decreased by 0.32 in the last 1 year

What is Debt to Equity?

Company's earnings are of high quality

Earnings quality score of 80.0 indicates that the company's earnings are of high quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion

What is Earnings quality score?

80.0 / 100

Consistently pays dividend

The company has not missed dividend payments once in the last 8 financial years

What is Dividend streak?

Negative

Expensive and at a premium to industry median P/E

PE TTM of 47.22 indicates that the stock is expensive on a standalone basis and is at a 55.89% premium to industry median P/E

What is P/E Ratio?

Median: 30.29

Value 47.22

0.33265.68

Low dividend yield

The company has a low dividend yield of 0.02%

What is Dividend yield?

Neutral

Not enough talking points with neutral stance

Financial Snapshot

See detailed analysis

Multi-year trends for Fredun Pharmaceuticals Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Fredun Pharmaceuticals Ltd. Shareholding Pattern

Quarterly breakdown of Fredun Pharmaceuticals Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Promoter	52.04	52.04	52.04	52.04	52.04	52.04	52.04	51.27	51.27	51.04	51.04	50.34	50.15	49.62	49.31	49.16	49.17	49.17	48.93	48.93	48.93	48.93	48.93	43.06	44.17	44.57
Indian Promoter	52.04	52.04	52.04	52.04	52.04	52.04	52.04	51.27	51.27	51.04	51.04	50.34	50.15	49.62	49.31	49.16	49.17	49.17	48.93	48.93	48.93	48.93	48.93	43.06	44.17	44.57
Foreign Promoter	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Institutions	3.11	2.82	1.93	1.88	1.88	1.88	7.20	1.69	1.69	1.68	1.68	1.66	1.65	1.64	1.60	1.60	1.60	1.60	1.59	1.59	1.59	1.59	1.61	3.94	3.89	4.00
Mutual Funds / UTI	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FI/Bank/Insurance	1.88	1.88	1.88	1.88	1.88	1.88	1.88	1.69	1.69	1.68	1.68	1.66	1.65	1.64	1.60	1.60	1.60	1.60	1.59	1.59	1.59	1.59	1.59	1.40	1.37	1.36
Govt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FII	1.23	0.94	0.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.46	1.06	1.06
Other Institutions	0.00	0.00	0.00	0.00	0.00	0.00	5.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.02	2.08	1.46	1.58
Non-Institution	44.85	45.14	46.03	46.08	46.08	46.08	40.77	47.04	47.04	47.27	47.27	48.00	48.20	48.74	49.09	49.25	49.24	49.24	49.48	49.48	49.48	49.48	49.45	53.00	51.94	51.43
Bodies Corporate	2.91	3.13	-	1.73	-	1.59	-	1.30	1.37	1.35	1.22	1.14	0.81	0.78	0.80	0.70	0.69	0.74	0.69	0.60	0.62	0.80	1.06	3.71	3.62	3.70
Others (incl. Retail) No. of shareholders	41.94 1,459	42.01 1,555	46.03 1,867	44.35 1,774	46.08 1,988	44.49 2,278	40.77 3,442	45.74 3,553	45.67 3,599	45.92 3,657	46.05 3,880	46.86 4,115	47.39 4,498	47.96 4,604	48.29 6,286	48.55 6,810	48.55 7,477	48.50 7,473	48.79 7,977	48.88 8,086	48.86 7,941	48.68 7,870	48.39 8,025	49.29 8,651	48.32 8,230	47.73 8,793

Holdings and Presence

Indices and prominent investors with a stake in this stock.

Index Presence

Fredun Pharmaceuticals Ltd. is not part of any tracked index.

Prominent Investor Holdings

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Fredun Pharmaceuticals Ltd. shares as reported to NSE and BSE.

Name	Month	Transaction	Holding % pre transaction	Average price	Qty.	Transaction value
Daulat Medhora Promoter & Director	April-2026	Conversion of security (Acquisition) 13th Apr 2026	25.78 %	₹ 1,250.00	40.00 k	₹ 5.00 cr
FREDUN MEDHORA Promoter & Director	March-2026	Conversion of security (Acquisition) 26th Mar 2026	3.35 %	₹ 1,250.00	1.07 lac	₹ 13.33 cr

Corporate Actions

History of Fredun Pharmaceuticals Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

Bonus2 new shares for 1 existing shares
Ex-date: 16th Jul 2026Announced on: 25th May 2026
Dividend₹ 0.70/share
Record date: 23rd Jun 2026Ex-date: 23rd Jun 2026
Announced on: 25th May 2026
Dividend₹ 0.70/share
Record date: 23rd Sep 2025Ex-date: 23rd Sep 2025
Announced on: 31st May 2025
Dividend₹ 0.70/share
Record date: 23rd Sep 2024Ex-date: 23rd Sep 2024
Announced on: 7th May 2024
Dividend₹ 0.70/share
Record date: 22nd Sep 2023Ex-date: 22nd Sep 2023
Announced on: 25th May 2023

Company Profile

Overview of Fredun Pharmaceuticals Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Fredun Pharmaceuticals Ltd. is an India-based pharmaceuticals formulation manufacturing company. The Company is engaged in manufacturing dietary/herbal supplements, nutraceuticals, and other healthcare products, along with animal healthcare products. Its segment includes Fredun Generics, Pet Care, N...

Key personnel

Vaishnavi Sahu

Compliance Officer, Company Secretary

Daulat Nariman MedhoraD

Executive Chairman of the Board, Joint Managing Director

Mr. Fredun Nariman MedhoraD

Chief Financial Officer, Managing Director, Executive Director

Mr. Anshu AgarwalD

Additional Non-Executive Independent Director

Ms. Niharika AgarwalD

Non-Executive Independent Director

Ms. Sonal DesaiD

Additional Non-Executive Independent Director

Ms. Daisy Cyril DsouzaD

Additional Non-Executive Independent Director

Ms. Pooja Narendra SanghaviD

Non-Executive Independent Director

View all

Incorporated on

08 Jun 1987

Last Annual

31 Mar 2026

Last Interim

30 Jun 2026

No. of Employees

736

IPO date

17 Mar 2016

Free Float

74,31,507

Website

http://www.fredungroup.com/pharmaceutical.html

Phone no.

+912240318111

Address

11th Floor, Tower A, Urmi Estate 95, Ganpatrao Kadam Marg Lower Parel (W), Delisle Road, , 400013, India

Frequently Asked Questions

What is the current share price of Fredun Pharmaceuticals Ltd.?

The current share price of Fredun Pharmaceuticals Ltd. is ₹ 1,223.50 as of 10 Aug 2026.

What is the market capitalisation of Fredun Pharmaceuticals Ltd.?

The market capitalisation of Fredun Pharmaceuticals Ltd. stands at ₹ 2,023.42 Cr.

What is the PE ratio of Fredun Pharmaceuticals Ltd.?

The Price-to-Earnings (PE) ratio of Fredun Pharmaceuticals Ltd. is 47.22 as of the latest trailing twelve months data.

What is the ROE and ROCE of Fredun Pharmaceuticals Ltd.?

Fredun Pharmaceuticals Ltd. has a Return on Equity (ROE) of 15.83% and a Return on Capital Employed (ROCE) of 20.05% as per the latest financial reports.

What is the 52-week high and low of Fredun Pharmaceuticals Ltd.?

The 52-week high of Fredun Pharmaceuticals Ltd. is - and the 52-week low is -.

What is the dividend yield of Fredun Pharmaceuticals Ltd.?

The dividend yield of Fredun Pharmaceuticals Ltd. is 0.02% based on the current market price.

What is the FII and DII holding in Fredun Pharmaceuticals Ltd.?

Foreign Institutional Investors (FII) hold 1.06%, Domestic Institutional Investors (DII) hold 1.36% and retail/public investors hold 47.73% of Fredun Pharmaceuticals Ltd. shares.

What sector does Fredun Pharmaceuticals Ltd. belong to?

Fredun Pharmaceuticals Ltd. operates in the Healthcare sector.

What is the beta of Fredun Pharmaceuticals Ltd.?

The beta of Fredun Pharmaceuticals Ltd. is 0.44, indicating its price volatility relative to the broader market. Over the past 1 year, Fredun Pharmaceuticals Ltd. has delivered an absolute return of 264.48%.

What is the RSI of Fredun Pharmaceuticals Ltd.?

The 14-day Relative Strength Index (RSI) of Fredun Pharmaceuticals Ltd. is 70.18, placing it in the overbought zone. An RSI above 70 is considered overbought and below 30 is considered oversold.

Fredun Pharmaceuticals Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Fredun Pharmaceuticals Ltd. Shareholding Pattern

Holdings and Presence

Bulk, Block and Insider Trades

Corporate Actions

Company Profile

Frequently Asked Questions

Stock Analysis

Company Profile

Holdings and Presence

Corporate Actions